SCM
RAPT

Sio Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Sio Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-39,375
Closed -$633K – 56
2024
Q3 		$633K Hold
39,375
– – 0.25% 30
2024
Q2 		$961K Hold
39,375
– – 0.26% 38
2024
Q1 		$2.83M Buy
+39,375
New +$5.47M 0.84% 34
2021
Q2 		– Sell
-1,787
Closed -$317K – 94
2021
Q1 		$317K Hold
1,787
– – 0.06% 86
2020
Q4 		$282K Hold
1,787
– – 0.06% 87
2020
Q3 		$460K Hold
1,787
– – 0.09% 82
2020
Q2 		$415K Hold
1,787
– – 0.12% 72
2020
Q1 		$304K Buy
+1,787
New +$407K 0.1% 62

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sio Capital Management's RAPT Position: Q4 2024 in Review

Sio Capital Management sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 39,375 shares — an estimated $633K sold.

Sio Capital Management first reported a position in RAPT in Q1 2020 and held it in 8 quarters. The position peaked at $2.83M in Q1 2024. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • Sio Capital Management reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Sio Capital Management sold 39,375 RAPT Therapeutics shares in Q4 2024, an estimated $633K.
  • Sio Capital Management first reported a position in RAPT Therapeutics in Q1 2020 and held it in 8 quarters.
  • Sio Capital Management's RAPT Therapeutics position peaked at $2.83M in Q1 2024.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Sio Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.